Evaluation of the Functional Assessment of Cancer Therapy Cognitive Scale with hematopoetic stem cell transplant patients

被引:86
作者
Jacobs, Sheri R.
Jacobsen, Paul B.
Booth-Jones, Margaret
Wagner, Lynne I.
Anasetti, Claudio
机构
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[2] Evanston NW Healthcare, Ctr Outcomes Res & Educ, Evanston, IL USA
[3] Northwestern Univ, Feinberg Med Sch, Chicago, IL 60611 USA
关键词
cancer; quality of life; cognitive functioning; QUALITY-OF-LIFE; ADULT SURVIVORS; BREAST-CANCER; ADJUVANT CHEMOTHERAPY; VALIDATION; FATIGUE;
D O I
10.1016/j.jpainsymman.2006.06.011
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The current study evaluated a newly developed self-report measure of cognitive complaints with cancer patients, the functional Assessment of Cancer Therapy Cognitive Scale (FACT-Cog). Six or 12 months following hematopoetic stem cell transplantation, participants completed a psychosocial assessment that included the FACT-Cog and a neuropsychological assessment. Using a criterion of two or more times a week, an average of 12 of a total of 50 items were endorsed as complaints on the FACT-Cog. FACT-Cog total, domain, and subscale scores were significantly correlated with measures of depression, fatigue, anxiety, and physical and mental well-being. FACT-Cog scores, with the exception of one subscale, Other People Noticed Deficits, were not significantly correlated with cognitive performance. In general, the FACT-Cog and a commonly used measure of cognitive complaints (European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire-C30 Cognitive Functioning Scale) demonstrated similar psychometric properties. However, the FACT-Cog assesses broader aspects of cognitive complaints, thereby providing greater information about the types of cognitive complaints patients are experiencing.
引用
收藏
页码:13 / 23
页数:11
相关论文
共 40 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   Cognitive effects of standard-dose chemotherapy in patients with cancer [J].
Ahles, TA ;
Saykin, A .
CANCER INVESTIGATION, 2001, 19 (08) :812-820
[3]   Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma [J].
Ahles, TA ;
Saykin, AJ ;
Furstenberg, CT ;
Cole, B ;
Mott, LA ;
Skalla, K ;
Whedon, MB ;
Bivens, S ;
Mitchell, T ;
Greenberg, ER ;
Silberfarb, PM .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) :485-493
[4]   Neuropsychological effects of treatments for adults with cancer: A meta-analysis and review of the literature [J].
Anderson-Hanley, C ;
Sherman, ML ;
Riggs, R ;
Agocha, VB ;
Compas, BE .
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2003, 9 (07) :967-982
[5]  
ANDRYKOWSKI MA, 1990, BONE MARROW TRANSPL, V6, P269
[6]  
ANDRYKOWSKI MA, 1989, BONE MARROW TRANSPL, V4, P505
[7]  
[Anonymous], 1991, National adult reading test (NART)
[8]   The center for epidemiologic studies depression scale as a measure of depressive symptoms in newly diagnosed patients [J].
Beeber, LS ;
Shea, J ;
McCorkle, R .
JOURNAL OF PSYCHOSOCIAL ONCOLOGY, 1998, 16 (01) :1-20
[9]  
Benton AL, 1983, Multilingual aphasia examination, V3rd
[10]   THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE [J].
CELLA, DF ;
TULSKY, DS ;
GRAY, G ;
SARAFIAN, B ;
LINN, E ;
BONOMI, A ;
SILBERMAN, M ;
YELLEN, SB ;
WINICOUR, P ;
BRANNON, J ;
ECKBERG, K ;
LLOYD, S ;
PURL, S ;
BLENDOWSKI, C ;
GOODMAN, M ;
BARNICLE, M ;
STEWART, I ;
MCHALE, M ;
BONOMI, P ;
KAPLAN, E ;
TAYLOR, S ;
THOMAS, CR ;
HARRIS, J .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :570-579